kastel 10 mg + 5 mg kapsułki twarde
egis pharmaceuticals plc - rosuvastatinum + ramiprilum - kapsułki twarde - 10 mg + 5 mg
kastel 20 mg + 10 mg kapsułki twarde
egis pharmaceuticals plc - rosuvastatinum + ramiprilum - kapsułki twarde - 20 mg + 10 mg
kastel 20 mg + 5 mg kapsułki twarde
egis pharmaceuticals plc - rosuvastatinum + ramiprilum - kapsułki twarde - 20 mg + 5 mg
kastel 10 mg + 10 mg kapsułki twarde
egis pharmaceuticals plc - ramiprilum + rosuvastatinum - kapsułki twarde - 10 mg + 10 mg
cystadane
recordati rare diseases - betaina bezwodna - homocystynuria - inne przewodu pokarmowego i przemianę materii narzędzia, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - Środki przeciwnowotworowe - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
rosuvastatin + acetylsalicylic acid adamed 5 mg + 100 mg kapsułki twarde
adamed pharma s.a. - rosuvastatinum calicum + acidum acetylsalicylicum - kapsułki twarde - 5 mg + 100 mg